0001209191-19-009916.txt : 20190213
0001209191-19-009916.hdr.sgml : 20190213
20190213201929
ACCESSION NUMBER: 0001209191-19-009916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190211
FILED AS OF DATE: 20190213
DATE AS OF CHANGE: 20190213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bujarski Robert Joseph
CENTRAL INDEX KEY: 0001333458
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 19600029
MAIL ADDRESS:
STREET 1: C/O QUIDEL CORPORATION
STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-11
0
0000353569
QUIDEL CORP /DE/
QDEL
0001333458
Bujarski Robert Joseph
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
SVP, Bus Dev & Gen Counsel
Common Stock
2019-02-11
4
A
0
2082
0.00
A
44950
D
Common Stock
2019-02-11
4
F
0
676
60.75
D
44274
D
Common Stock
2019-02-11
4
A
0
624
0.00
A
44898
D
Common Stock
2019-02-11
4
F
0
213
60.75
D
44685
D
Restricted Stock Units (Converted)
2019-02-11
4
A
0
2749
0.00
A
Common Stock
2749
2749
D
Restricted Stock Units (Premium)
2019-02-11
4
A
0
824
0.00
A
Common Stock
824
824
D
Reflects vesting of prior restricted stock units, which were previously reported on a Form 4.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
The restricted stock units vest on the date of the grant, February 11, 2019.
The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan.
The restricted stock units vest on the first anniversary date of the grant date, February 11, 2020.
Robert J. Bujarski
2019-02-13